Mereo BioPharma Group plc (FRA:MAH0)
1.685
-0.040 (-2.32%)
At close: Dec 5, 2025
Mereo BioPharma Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -41.57 | -43.25 | -29.47 | -42.22 | 17.23 | -223.4 | Upgrade
|
| Depreciation & Amortization | 0.83 | 1.09 | 1.06 | 0.89 | 0.87 | 2.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -0.15 | 14.84 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.05 | Upgrade
|
| Stock-Based Compensation | 7.57 | 7.39 | 4.92 | 4.77 | 4.47 | 2.13 | Upgrade
|
| Other Operating Activities | 0.56 | 2.31 | 3.94 | -9.91 | -27.01 | 170.26 | Upgrade
|
| Change in Accounts Receivable | - | - | - | - | -0.8 | 0.19 | Upgrade
|
| Change in Accounts Payable | -0.98 | 0.15 | -1.26 | 0.62 | -1.7 | -4.85 | Upgrade
|
| Change in Other Net Operating Assets | 0.88 | -0.52 | -0.33 | -2.97 | - | - | Upgrade
|
| Operating Cash Flow | -32.71 | -32.83 | -21.13 | -48.82 | -7.09 | -38.69 | Upgrade
|
| Capital Expenditures | -0.02 | - | - | -0.01 | -0.72 | -0.02 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -0.48 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.7 | -0.42 | 2 | 0.15 | 2.49 | Upgrade
|
| Other Investing Activities | - | - | - | - | 0 | 0.06 | Upgrade
|
| Investing Cash Flow | -0.02 | -0.7 | -0.42 | 1.99 | -0.57 | 2.04 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 60.59 | Upgrade
|
| Long-Term Debt Repaid | - | - | -3.19 | - | -0.94 | -29.88 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -3.19 | - | -0.94 | 30.7 | Upgrade
|
| Issuance of Common Stock | 0.49 | 47 | 11.61 | - | 106.4 | 27.49 | Upgrade
|
| Other Financing Activities | -0.24 | -0.85 | -0.44 | 0.2 | -0.32 | -10.77 | Upgrade
|
| Financing Cash Flow | 0.25 | 46.15 | 7.97 | 0.2 | 105.15 | 47.43 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.66 | -0.23 | 2.82 | -12.58 | -1.58 | -1.05 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | - | - | - | Upgrade
|
| Net Cash Flow | -31.82 | 12.38 | -10.76 | -59.22 | 95.9 | 9.72 | Upgrade
|
| Free Cash Flow | -32.73 | -32.83 | -21.13 | -48.83 | -7.82 | -38.72 | Upgrade
|
| Free Cash Flow Margin | -6545.80% | - | -211.32% | - | -15.83% | - | Upgrade
|
| Free Cash Flow Per Share | -0.21 | -0.22 | -0.16 | -0.41 | -0.07 | -0.57 | Upgrade
|
| Cash Interest Paid | 0.03 | 0.02 | 0.88 | 0.02 | - | 3.96 | Upgrade
|
| Cash Income Tax Paid | - | - | -1.34 | 1.88 | - | - | Upgrade
|
| Levered Free Cash Flow | -20.15 | -21.5 | -14.17 | -32.74 | -9.08 | -25.67 | Upgrade
|
| Unlevered Free Cash Flow | -19.77 | -20.64 | -12.37 | -30.13 | -5.88 | -20.36 | Upgrade
|
| Change in Working Capital | -0.1 | -0.37 | -1.59 | -2.35 | -2.5 | -4.66 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.